TD Waterhouse Canada »

Briacell Therapeutics Corp shares owned by TD Waterhouse Canada

Quarter-by-quarter ownership of Briacell Therapeutics Corp shares owned by TD Waterhouse Canada from 13F filings

Historical chart of TD Waterhouse Canada investment in Briacell Therapeutics Corp

Tip: Access up to 7 years of quarterly data

All positions including Briacell Therapeutics Corp held by TD Waterhouse Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Briacell Therapeutics Corp by TD Waterhouse Canada

Quarter filed Position value Share count Share price at filing
2025-12-31 $135 19 7.11
2025-09-30 $237 19 12.53

More positions owned by TD Waterhouse Canada

Rbc Cad (RY)
Toronto Dominion Bk Ont Com New (TD)
Microsoft Corporation (MSFT)
Apple (AAPL)
Enbridge (ENB)
Bk Nova Cad (BNS)
JPMorgan Chase & Co. (JPM)
Cibc Cad (CM)
Bank Of Montreal Cadcom (BMO)
Brookfield Corp Cl A Ltd Vt Sh (BN)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Fortis (FTS)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Tc Energy Corp (TRP)

View all positions for TD Waterhouse Canada

Top funds holding Briacell Therapeutics Corp

Citadel Advisors
Federation des caisses Desjardins du Quebec
UBS Group
Royal Bank of Canada
SBI Securities
Group One Trading
TD Waterhouse Canada
FNY Investment Advisers
Hanson McClain Advisors
HHM Wealth Advisors
Advisor Group Holdings
Wells Fargo & Company

View all funds holding Briacell Therapeutics Corp